Posted in: Triangle Times Today

Volume 5 | Issue 3 | March 2026

Artificial Intelligence: AAAHC’s Framework for Responsible Implementation

Artificial Intelligence (AI) has transitioned from theoretical promise to practical reality in ambulatory care settings. Today’s ambulatory organizations use AI to schedule appointments, document clinical encounters, and manage quality metrics. As adoption accelerates, AAAHC emphasizes the need for safe, responsible AI implementation that enhances patient-centered care.

Current AI Applications in Ambulatory Care
Most real-world AI applications in ambulatory care focus on reducing administrative burden rather than replacing clinical judgment. Ambient AI scribes listen during patient visits and generate draft documentation in Electronic Health Records (EHRs). Organizations deploy AI-powered tools for patient intake, appointment scheduling, call center automation, and messaging systems. Revenue cycle management increasingly incorporates AI for coding support, risk adjustment, and denial prediction.

Emerging research demonstrates meaningful benefits, particularly for documentation efficiency and clinician well-being. Multisite quality improvement studies of ambient AI scribes in ambulatory clinics show significant reductions in burnout, after-hours charting time, decreased cognitive load, and increased patient attention during visits. Pilot data from surgical outpatient settings suggest ambient scribes may enable clinicians to see more patients per session, although the effects on billing and productivity remain inconsistent and require longer-term evaluation.

Nevertheless, scoping reviews emphasize most AI tools for ambulatory care remain in developmental or pilot phases, with limited high-quality comparative trials demonstrating clinical efficacy.

Risk Management and Regulatory Evolution
Clinical AI implementation carries substantial risks. Large language models can generate plausible but inaccurate clinical content—also known as “hallucinations”—and targeted adversarial prompts have induced erroneous recommendations in simulated clinical scenarios. Algorithmic biases threaten to perpetuate or amplify health disparities.

Converging guidance from the Food and Drug Administration (FDA) Digital Health Center of Excellence, the National Academy of Medicine’s AI code of conduct, and the Coalition for Health AI emphasizes transparency, fairness, safety monitoring, and continuous performance evaluation.

Within AAAHC-accredited organizations, the governing body plays a central role in determining whether AI enhances safe, high-quality care. AAAHC’s Governance (GOV) Standards assign the organization’s governing body ultimate responsibility for defining the scope of services, approving major contracts, and ensuring all operations, including AI-enabled tools and vendor solutions, are consistent with the organization’s mission, risk tolerance, and quality priorities (GOV.160; GOV.170; GOV.200).

In practice, this means the governing body must actively oversee AI strategy, establish clear accountability for AI risk management and quality oversight, and verify AI use is integrated into the organization’s ongoing evaluation of performance, patient safety, and equity
(GOV.190; GOV.240).

By setting expectations for human oversight, reviewing the impact of AI on clinical workflows and outcomes, and directing corrective action when needed, the governing body fulfills its responsibility to ensure AI supports, rather than substitutes for, sound clinical judgment and organizational governance.

Implementation Guidance
AAAHC-accredited organizations should prioritize strategic thinking over technological novelty, implementing natural intelligence before artificial intelligence. Practical steps include identifying specific problems, such as documentation burden, no-show rates, or care gaps, before selecting AI solutions. Early engagement with clinicians, information technology staff, compliance officers, and patients shapes effective workflows, consent processes, and communication strategies.

Organizations should integrate AI into quality improvement programs with comprehensive metrics spanning financial performance, access equity, user experience, clinical outcomes, and operational efficiency. As AI capabilities mature, AAAHC will continue emphasizing Standards that advance innovation rather than undermine the trust fundamental to ambulatory care.

Leading with Intent: Risk Management in Health Care

As March 2026 marks a renewed, sector-wide focus on patient safety, health care leaders have an ideal opportunity to sharpen organizational risk management strategies. Earlier this month, Patient Safety Awareness Week provided an ongoing reminder that preventing harm must be a year-round, daily priority. Effective risk management is foundational to patient trust, financial stability, and clinical excellence. For organizations seeking
or holding AAAHC Accreditation, the alignment between accreditation philosophy and risk management can amplify impact.

Health care delivery carries inherent clinical, operational, financial, and reputational risks. Adverse safety events— such as medication errors, diagnostic mishaps, infection outbreaks, or patient falls—carry human and institutional costs. Leaders must cultivate systems that anticipate, detect, mitigate, and learn from risk. Visible leadership involvement signals commitment: town halls, safety rounds, incident-reporting campaigns, and near-miss debriefs reinforce safety is everyone’s responsibility.

The 1095 Strong, quality every day philosophy drives meaningful impact to ambulatory care
The AAAHC Accreditation model is built on sustaining quality across the entire three-year cycle—1,095 days—not just around the survey window. This approach dovetails neatly with proactive risk management: rather than reacting only when problems arise, accredited organizations embed continuous readiness and improvement into their culture. AAAHC’s tools, education resources, and accreditation processes encourage ongoing self-assessment, early detection of gaps, and planned corrective action.

Strategic Risk Management Steps for Safety Leaders
1. Conduct a Risk Inventory and Prioritization
Use cross-functional teams, such as clinical, compliance, and operations, to review potential vulnerabilities, (e.g., sterile processing, credentialing, emergency response, and information technology security). Rank risks by severity, frequency, and controllability (SAF.100). The AAAHC Self-Assessment Tool helps guide audit and gap identification.

2. Integrate Risk Management with Quality Improvement (QI) Program
Align risk mitigation with your QI framework (QUA.210). Each high-risk issue should trigger a performance improvement project with measurable goals, timelines, and accountability. AAAHC expects documented corrective actions and followup monitoring.

3. Strengthen Policies, Protocols, and Training
Ensure policies for infection control, medication safety, credentialing, and emergency care are current and accessible. Train staff regularly, simulate drills (e.g., code events, equipment failures), and assess competency. AAAHC Standards place emphasis on orientation and training for staff and clinicians (ADM.150-160).

4. Foster a Culture of Reporting and Transparency
Encourage reporting of near misses and adverse safety events without fear of punishment. Use root-cause analysis and share lessons learned transparently across departments. The culture shift from blame to learning reduces hidden risks.

5. Promote Executive Visibility and Accountability
This is the moment for visible leadership: walk the units, engage with front-line staff, review data in leadership huddles, and commit to specific risk reduction goals publicly. Leaders should also review risk dashboards weekly or monthly.

6. Ensure Board and Governance Oversight
The board should receive regular reporting on risk trends, mitigation strategies, and QI outcomes (GOV.190). Governing bodies must ensure resource allocation aligns with risk priorities. AAAHC Standards expect robust governance oversight of quality and safety.

Catalyze Enduring Change Through Patient Safety
Patient safety leads to longer-term transformation. Implement safety sprints and pilot improvements throughout the month, such as optimizing handoff protocols and standardizing high-alert medications, measure impact, and scale successful pilots. Reinforce periodic check-ins and audits throughout the accreditation cycle.

By embedding the AAAHC 1095 Strong, quality every day philosophy into your risk management strategy, leaders can move from episodic efforts to a resilient, anticipatory safety culture. Make patient safety your launchpad for lasting institutional maturity and protection of patients, staff, and the organization as a whole.

Enhance Thyroid Health

Thyroid disorders affect millions of Americans, influencing metabolism, energy levels, and overall well-being. In ambulatory care settings, ensuring high-quality thyroid health management aligns with AAAHC Standards, which emphasize patient-centered care, safety, and continuous quality improvement.

Effective thyroid care begins with a comprehensive assessment and a timely diagnosis. According to the AAAHC Standard CMC.100, organizations must provide care consistent with the standard of care, including appropriate historical documentation, physical examination, and medication reconciliation. For patients with hypothyroidism or hyperthyroidism, this means accurate lab testing, clinical evaluation, and individualized treatment plans.

Patient education is equally vital. Standard CMC.110 requires informing patients about their condition, treatment options, and follow-up care. This empowers individuals to manage their thyroid health to improve adherence and outcomes proactively.

Finally, AAAHC encourages ongoing quality improvement. Monitoring thyroid treatment outcomes, patient experience, and peer review supports Standard QUA.210 and reinforces a culture of excellence.

By integrating AAAHC Standards into thyroid health services, ambulatory care organizations not only meet AAAHC Accreditation requirements but also elevate patient care—ensuring that every thyroid patient receives safe, effective, and compassionate treatment.

Specialty Corner

Ophthalmology in the Ambulatory Surgery Center (ASC) Setting

Ophthalmology remains one of the most efficiently delivered specialties in the ASC environment, supported by standardized workflows, predictable scheduling, and high procedural throughput. Cataract extraction, glaucoma procedures, and retinal interventions benefit from the ASC model, which emphasizes controlled environments and consistent adherence to evidence‑based practices. Compliance with AAAHC Standards strengthens operational reliability and ensures alignment with national expectations for ambulatory surgical care.

The AAAHC Standard IPC.170 establishes requirements for sterilization and high‑level disinfection processes, including oversight of instrument reprocessing, documentation of sterilization cycles, and validation of staff competency. This AAAHC Standard is essential for ophthalmology, where microsurgical instruments, phacoemulsification handpieces, and implantable lenses require precise handling, traceability, and contamination‑prevention measures.

Similarly, privileging processes confirm individuals performing ophthalmic procedures have the appropriate training, experience, and demonstrated competency are defined in Standard CPV.230. This AAAHC Standard ensures verification of qualifications for laser procedures, intraocular lens implantation, and anesthesia-related responsibilities within the ophthalmic specialty.

Integration of these AAAHC Standards enhances consistent clinical outcomes, minimizes procedural variability, and strengthens patient safety. Maintaining compliance with AAAHC requirements throughout the 1,095-day accreditation cycle enables ophthalmology ASCs to sustain a high-reliability environment that promotes efficient surgical care and drives continuous quality improvement.

AAAHC Standards Interpretation

Guidance on multi-dose eye drops

In June 2022, the Centers for Medicare & Medicaid Services (CMS) issued important clarification on the use of multi-dose ophthalmic preparations—a topic that has led to questions and occasional citations issued by AAAHC Surveyors during accreditation surveys. The guidance confirms the 28-day discard rule for opened injectable medications does not apply to multi-dose eye drops. Instead, these products may be used according to the manufacturer’s labeled expiration date, provided that nationally recognized infection control standards are also strictly followed. This article is intended to help organizations understand how AAAHC Surveyors assess compliance with this guidance, clarify distinctions between multi-dose and single-use containers, and prevent infection control citations related to improper medication handling.

Key points of the CMS guidance:

  • Extended expiration date
    The 28-day discard rule for opened multi-dose injectable drugs does not apply to multi-dose eye drops. When opened, multi-dose eye drops generally follow the manufacturer’s expiration date unless a different in-use date is specified by the manufacturer.
  • Multiple-patient use
    Multi-dose eye drops can be used for more than one patient in a clinical setting, as long as strict aseptic techniques and standard precautions are followed to prevent cross-contamination.
  • Aseptic techniques required
    Facilities must implement robust infection control protocols and provide staff training to enhance the safe, multi-patient use of these eye drops. Dropper tips should never make contact with the patient’s eye or any other surface.
  • Distinction from single-use
    The CMS guidance clearly differentiates multi-dose eye drops from single-use vials. Eye drops labeled for single use must be discarded immediately after a single-patient use.

Essentially, organizations using multi-dose eye drop bottles for multiple patients must follow the instructions on the labeling to minimize inadvertent contamination of any medications through direct contact with potentially contaminated surfaces that could lead to infections in subsequent patients.

If AAAHC Surveyors observe eye drops known to be contaminated and/or using eye drop medications labeled as single-patient use only on multiple patients, the organization will be cited under the appropriate infection control requirement.

According to CMS, eye drop medications labeled as multi-dose may be used for more than one patient only if aseptic techniques and standard precautions are followed. Any medication labeled as single use must be discarded immediately after use on a single patient.

Conferences & Exhibits

  • Association of periOperative Registered Nurses (AORN), April 11–14, New Orleans, LA
  • Progressive Surgical Solutions, April 17–18, Dallas, TX
  • Ambulatory Surgery Center Association (ASCA), May 13–16, Washington, D.C
  • American College Health Association (ACHA), May 26–30, Denver, CO

1095 Learn

2026 Achieving Accreditation

  • September 14–16, Virtual
  • December 10–11, Red Rock Casino Resort and Spa, Las Vegas, NV

Learn more about upcoming Achieving Accreditation programs

Download the March 2026 newsletter